Ginsenoside C

Star0

DB06748ExperimentalNutraceuticalSmall molecule

Ginsenoside C: Overview.

Mechanism: Pharmacologically active on Transforming growth factor beta-1 proprotein
Curator reviewed
Formula / weight: C₅₃H₉₀O₂₂ · 1079.281 g/mol (avg)
Also known as: ginsenoside Rb2
Code names: NSC-308878

Resolves to

Compound

UNIIN219O0L31CCAS11021-13-9ChEMBLCHEMBL449303ChEBI77152PubChem6917976

Structure

InChIKeyNODILNFGTFIURN-GZPRDHCNSA-NSMILES

[H][C@@]1(CC[C@]2(C)[C@]1([H])[C@H](O)C[C@]1([H])[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@]3([H])CC[C@@]21C)[C@](C)(CCC=C(C)C)O[C@@H]1O[C@H](CO[C@@H]2OC[C@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O

Targets

P01137TGFB1P99999CYCSP33261CYP2C19

What you can answer from here — as of July 03, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

39Drug interactionsStructured to mechanism, not free text

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ginsenoside C, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account